SUSD2 and neoplasm: The results demonstrated that low expression of SUSD2 was positively correlated with tumor advanced clinical stage (χ2 = 30.244, P < 0.05), pT status (χ2 = 33.175, P < 0.05), pN status (χ2 = 4.785, P < 0.05) and histological grade (χ2 = 5.198, P < 0.05), pM status (χ2 = 4.620, P < 0.05).